3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
7
Colorectal Neoplasms
7
Neoplasms
6
Breast Neoplasms
6
Lung Neoplasms
4
Uterine Cervical Dysplasia
2
Prostatic Neoplasms
2
Papillomavirus Infections
2
End Stage Liver Disease
2
Warts
1
Urinary Bladder Neoplasms
1
Tinea
1
Smoking
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Nevus
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Molluscum Contagiosum
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Cancer Screening
1
Liver Neoplasms
1
Kidney Failure, Chronic
1
Keratosis, Actinic
1
Intestinal Neoplasms
1
Impetigo
1
Herpes Zoster
1
Hepatitis C
1
Heart Diseases
1
Interventions
Doxorubicin
20
Vincristine
17
Zidovudine
13
Cyclophosphamide
12
Bleomycin
12
Etoposide
10
Rituximab
6
Prednisone
6
Interferon alpha-2
6
Cytarabine
6
Liposomes
5
Filgrastim
5
Dexamethasone
5
tecogalan
4
sargramostim
4
Specimen Handling
4
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Fluorouracil
4
Biopsy
4
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Nivolumab
3
interferon alfa-n1
2
fludarabine phosphate
2
fludarabine
2
cabozantinib
2
Whole-Body Irradiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
HIV Infections
×
Mass Screening
×
Clear all
NCT07225530
2026-02-25
(iSTAR)
Columbia University
Phase NA
Recruiting
600 enrolled